p. 1151−1154
2476-762X
Vol.19/No.5
p. 1155−1155
2476-762X
Vol.19/No.5
p. 1157−1160
2476-762X
Vol.19/No.5
p. 1161−1167
2476-762X
Vol.19/No.5
p. 1169−1173
2476-762X
Vol.19/No.5
p. 1175−1180
2476-762X
Vol.19/No.5
p. 1181−1184
2476-762X
Vol.19/No.5
0.05). Conclusion: We conclude that UNC5C hypermethylationis implicated in CRC which plays a role in its tumorigenesis and may predict the late stage disease.]]>
p. 1185−1188
2476-762X
Vol.19/No.5
p. 1189−1193
2476-762X
Vol.19/No.5
p. 1195−1199
2476-762X
Vol.19/No.5
p. 1201−1207
2476-762X
Vol.19/No.5
p. 1209−1214
2476-762X
Vol.19/No.5
p. 1215−1221
2476-762X
Vol.19/No.5
p. 1223−1227
2476-762X
Vol.19/No.5
p. 1229−1236
2476-762X
Vol.19/No.5
p. 1237−1242
2476-762X
Vol.19/No.5
p. 1243−1249
2476-762X
Vol.19/No.5
p. 1251−1257
2476-762X
Vol.19/No.5
p. 1259−1262
2476-762X
Vol.19/No.5
p. 1263−1268
2476-762X
Vol.19/No.5
p. 1269−1275
2476-762X
Vol.19/No.5
p. 1277−1280
2476-762X
Vol.19/No.5
p. 1281−1286
2476-762X
Vol.19/No.5
p. 1287−1293
2476-762X
Vol.19/No.5
p. 1295−1302
2476-762X
Vol.19/No.5
p. 1303−1311
2476-762X
Vol.19/No.5
p. 1313−1318
2476-762X
Vol.19/No.5
420 U/ ml (p value <0.001), the presence of livermetastasis on preoperative imaging (p value: 0.041) and ascites (p value: 0.032) or massive ascites (p value:0.010)significantly increased the risk of suboptimal debulking (logit p = 2.36 CA125 level +1.85 Liverinvolvement +1.68presence of Ascites+ 2.28 Massive Ascites). Conclusion:The present study suggests that a serum CA125 level >420 U/ml,the presence of ascites or massive ascites and liver metastasis are strong predictors of suboptimal primary surgery incases of EOC. Based on the constructed model, with any of these 4 factors, the probability of suboptimal debulking inEOC is more than 80%.]]>
p. 1319−1324
2476-762X
Vol.19/No.5
p. 1325−1330
2476-762X
Vol.19/No.5
p. 1331−1336
2476-762X
Vol.19/No.5
p. 1337−1341
2476-762X
Vol.19/No.5
p. 1343−1349
2476-762X
Vol.19/No.5
p. 1351−1355
2476-762X
Vol.19/No.5
p. 1357−1362
2476-762X
Vol.19/No.5
p. 1363−1366
2476-762X
Vol.19/No.5
p. 1367−1373
2476-762X
Vol.19/No.5
p. 1375−1379
2476-762X
Vol.19/No.5
p. 1381−1385
2476-762X
Vol.19/No.5
p. 1387−1395
2476-762X
Vol.19/No.5
p. 1397−1404
2476-762X
Vol.19/No.5
p. 1405−1410
2476-762X
Vol.19/No.5
p. 1411−1413
2476-762X
Vol.19/No.5
p. 1415−1423
2476-762X
Vol.19/No.5